QuintilesIMS Reports Fourth-Quarter and Full-Year 2016 Results, Issues First-Quarter and Full-Year 2017 Guidance
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Quintiles IMS Holdings, Inc. (NYSE:Q), a leading global provider of information, technology services and contract research to the healthcare and life sciences industries, today reported financial results for the quarter and full-year ended December 31, 2016. On October 3, 2016, the merger of Quintiles Transnational Holdings Inc. and IMS Health Holdings, Inc. was completed. To aid investors and analysts with year-over-year comparability for the merged business, we are providing combined company financial information, which combines the stand-alone Quintiles and IMS Health financial information for revenue and Adjusted EBITDA as if the merger had taken place on January 1, 2015, with conforming adjustments to the current year presentation.
- Revenue of $1,953 million, up 74.2 percent constant currency, 73.1 percent reported; on a combined company basis up 4.2 percent constant currency, 3.5 percent at actual FX rates when adjusting for $55 million of deferred revenue for the fourth quarter
- Adjusted EBITDA of $541 million, up 129.2 percent constant currency, 133.7 percent reported; on a combined company basis up 14.5 percent constant currency, 16.7 percent reported for the fourth quarter
- Diluted GAAP Loss per Share of $0.74; Adjusted Diluted Earnings per Share of $1.09 for the fourth quarter
- Post-merger share repurchase authorization increased to $2.5 billion from $1.5 billion
Andrew Markwick, 1 973-257-7144
Tor Constantino, 1 484-567-6732